A detailed history of Pnc Financial Services Group, Inc. transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 319 shares of ENTA stock, worth $2,979. This represents 0.0% of its overall portfolio holdings.

Number of Shares
319
Previous 319 -0.0%
Holding current value
$2,979
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$11.43 - $17.02 $20,951 - $31,197
-1,833 Reduced 85.18%
319 $4,000
Q1 2024

May 10, 2024

BUY
$10.08 - $17.46 $19,535 - $33,837
1,938 Added 905.61%
2,152 $37,000
Q4 2023

Feb 09, 2024

SELL
$8.18 - $10.78 $6,781 - $8,936
-829 Reduced 79.48%
214 $2,000
Q3 2023

Nov 13, 2023

SELL
$11.09 - $22.13 $19,163 - $38,240
-1,728 Reduced 62.36%
1,043 $11,000
Q2 2023

Aug 11, 2023

BUY
$20.68 - $39.85 $34,080 - $65,672
1,648 Added 146.75%
2,771 $59,000
Q1 2023

May 15, 2023

BUY
$38.82 - $54.59 $2,717 - $3,821
70 Added 6.65%
1,123 $45,000
Q4 2022

Feb 10, 2023

SELL
$40.77 - $53.73 $163 - $214
-4 Reduced 0.38%
1,053 $48,000
Q3 2022

Nov 10, 2022

BUY
$48.29 - $71.27 $25,786 - $38,058
534 Added 102.1%
1,057 $54,000
Q2 2022

Aug 12, 2022

SELL
$38.13 - $76.93 $23,526 - $47,465
-617 Reduced 54.12%
523 $24,000
Q1 2022

May 12, 2022

BUY
$56.06 - $74.11 $1,513 - $2,000
27 Added 2.43%
1,140 $81,000
Q4 2021

Feb 11, 2022

BUY
$60.19 - $97.37 $9,209 - $14,897
153 Added 15.94%
1,113 $83,000
Q3 2021

Nov 05, 2021

SELL
$41.02 - $58.65 $26,293 - $37,594
-641 Reduced 40.04%
960 $54,000
Q2 2021

Aug 06, 2021

BUY
$43.76 - $53.11 $35,620 - $43,231
814 Added 103.43%
1,601 $70,000
Q1 2021

May 07, 2021

BUY
$41.69 - $54.95 $9,838 - $12,968
236 Added 42.83%
787 $38,000
Q4 2020

Feb 12, 2021

SELL
$41.16 - $47.47 $21,938 - $25,301
-533 Reduced 49.17%
551 $23,000
Q3 2020

Nov 06, 2020

BUY
$43.36 - $53.53 $563 - $695
13 Added 1.21%
1,084 $49,000
Q2 2020

Aug 07, 2020

BUY
$46.37 - $57.58 $139 - $172
3 Added 0.28%
1,071 $53,000
Q1 2020

May 08, 2020

BUY
$40.22 - $62.0 $12,106 - $18,662
301 Added 39.24%
1,068 $54,000
Q4 2019

Feb 07, 2020

BUY
$57.95 - $66.61 $1,390 - $1,598
24 Added 3.23%
767 $47,000
Q3 2019

Nov 08, 2019

SELL
$60.08 - $88.17 $1,982 - $2,909
-33 Reduced 4.25%
743 $44,000
Q2 2019

Aug 09, 2019

BUY
$81.3 - $97.35 $2,764 - $3,309
34 Added 4.58%
776 $0
Q1 2019

May 10, 2019

BUY
$69.08 - $105.66 $7,460 - $11,411
108 Added 17.03%
742 $0
Q4 2018

Feb 08, 2019

BUY
$65.41 - $84.65 $16,287 - $21,077
249 Added 64.68%
634 $44,000
Q3 2018

Nov 09, 2018

BUY
$85.46 - $126.37 $1,281 - $1,895
15 Added 4.05%
385 $0
Q2 2018

Aug 10, 2018

BUY
$81.85 - $120.51 $8,512 - $12,533
104 Added 39.1%
370 $0
Q1 2018

May 11, 2018

BUY
$57.91 - $92.15 $5,733 - $9,122
99 Added 59.28%
266 $0
Q4 2017

Feb 09, 2018

SELL
$45.65 - $59.37 $136 - $178
-3 Reduced 1.76%
167 $0
Q3 2017

Nov 13, 2017

BUY
$37.91 - $46.8 $6,444 - $7,955
170
170 $0

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $194M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.